Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Toren Penny — Vallon Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Toren Penny

Toren Penny

SVP, Regul Affairs & Prog Mgmt at Vallon Pharmaceuticals, Inc. · on record since Feb 9, 2021

Insider trading activity of Toren Penny

Transactions on record: 1; since May 18, 2021

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing May 18, 2021

Figures computed from official regulatory filings — methodology.

Companies where Toren Penny has traded

Vallon Pharmaceuticals, Inc.1 tx · May 18, 2021

Track record of Toren Penny

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Toren Penny

Co-insiders of Toren Penny

Agro AlbertVallon Pharmaceuticals, Inc.
Ammer RichardVallon Pharmaceuticals, Inc.
Arcturus Therapeutics Holdings Inc.Vallon Pharmaceuticals, Inc.
Baker David CharlesVallon Pharmaceuticals, Inc.
Chaturvedi VipinVallon Pharmaceuticals, Inc.
Chhabra MeenuVallon Pharmaceuticals, Inc.
Hertz Walter MarcVallon Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Kelly Leanne M.Vallon Pharmaceuticals, Inc.

Levi OfirVallon Pharmaceuticals, Inc.

Payne Joseph EVallon Pharmaceuticals, Inc.

Rongen RoelofVallon Pharmaceuticals, Inc.

SALMON Pharma GmbHVallon Pharmaceuticals, Inc.

SIMPSON CAMILLA VVallon Pharmaceuticals, Inc.

Szekeres David LeslieVallon Pharmaceuticals, Inc.

Thorell MarellaVallon Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Vallon Pharmaceuticals, Inc.	May 18, 2021	AwardD	25,000	0.00 USD	$0	SEC